Das, R A <br/><br/>
Combined treatment modalities for age related macular degeneration.  [electronic resource] 

 -  Current drug targets  Feb 2011 
 - 182-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1873-5592 
<br/><br/><label>Standard No.: </label>10.2174/138945011794182719  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Blindness--etiology<br/>Choroidal Neovascularization--drug therapy<br/>Combined Modality Therapy--trends<br/>Dexamethasone--therapeutic use<br/>Disease Progression<br/>Glucocorticoids--therapeutic use<br/>Humans<br/>Macular Degeneration--drug therapy<br/>Photochemotherapy<br/>Photosensitizing Agents--pharmacology<br/>Porphyrins--pharmacology<br/>Vascular Endothelial Growth Factors--antagonists & inhibitors<br/>Verteporfin<br/>Wet Macular Degeneration--drug therapy